Subclinical hyperthyroidism is defined as the presence of serum free thyroxine (T4) and triiodothyronine (T3) levels within the reference range and a reduced serum thyrotrophin (TSH) level. Evidence is accumulating that it has important clinical effects. The SUBstudy is a randomised, Dutch multicenter trial to study whether radioiodine treatment prevents the development of atrial fibrillation and prevents decreases in bone mineral density in patients with endogenous subclinical hyperthyroidism.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
200
Academical Medical Centre Amsterdam
Amsterdam, Netherlands
RECRUITINGMartini Ziekenhuis Groningen
Groningen, Netherlands
RECRUITINGUniversity Hospital Groningen
Groningen, Netherlands
RECRUITINGTo provide evidence that restoration of euthyroidism (normal TSH) improves thyrotoxic symptoms and signs and quality of life and lowers the risk of subsequent atrial fibrillation and bone loss in subjects with endogenous subclinical hyperthyroidism
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Radboud University Medical Centre Nijmegen
Nijmegen, Netherlands
RECRUITINGMaxima Medisch Centrum
Veldhoven, Netherlands
RECRUITING